Literature DB >> 33498493

The Role of Hepatic Fat Accumulation in Glucose and Insulin Homeostasis-Dysregulation by the Liver.

Amalie London1,2, Anne-Marie Lundsgaard2, Bente Kiens2, Kirstine Nyvold Bojsen-Møller1.   

Abstract

Accumulation of hepatic triacylglycerol (TG) is associated with obesity and metabolic syndrome, which are important pathogenic factors in the development of type 2 diabetes. In this narrative review, we summarize the effects of hepatic TG accumulation on hepatic glucose and insulin metabolism and the underlying molecular regulation in order to highlight the importance of hepatic TG accumulation for whole-body glucose metabolism. We find that liver fat accumulation is closely linked to impaired insulin-mediated suppression of hepatic glucose production and reduced hepatic insulin clearance. The resulting systemic hyperinsulinemia has a major impact on whole-body glucose metabolism and may be an important pathogenic step in the development of type 2 diabetes.

Entities:  

Keywords:  glucose metabolism; hepatic glucose production; hyperinsulinemic-euglycemic clamp; insulin clearance; insulin resistance; molecular regulation; non-alcoholic fatty liver disease (NAFLD); proton MR spectroscopy

Year:  2021        PMID: 33498493      PMCID: PMC7864173          DOI: 10.3390/jcm10030390

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  94 in total

1.  Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease.

Authors:  Naoki Kumashiro; Derek M Erion; Dongyan Zhang; Mario Kahn; Sara A Beddow; Xin Chu; Christopher D Still; Glenn S Gerhard; Xianlin Han; James Dziura; Kitt Falk Petersen; Varman T Samuel; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  A systematic analytical chemistry/cell assay approach to isolate activators of orphan nuclear receptors from biological extracts: characterization of peroxisome proliferator-activated receptor activators in plasma.

Authors:  C D Banner; M Göttlicher; E Widmark; J Sjövall; J J Rafter; J A Gustafsson
Journal:  J Lipid Res       Date:  1993-09       Impact factor: 5.922

3.  Hypothesis: Role of Reduced Hepatic Insulin Clearance in the Pathogenesis of Type 2 Diabetes.

Authors:  Richard N Bergman; Francesca Piccinini; Morvarid Kabir; Cathryn M Kolka; Marilyn Ader
Journal:  Diabetes       Date:  2019-09       Impact factor: 9.461

4.  Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver.

Authors:  Justin A Fletcher; Stanisław Deja; Santhosh Satapati; Xiaorong Fu; Shawn C Burgess; Jeffrey D Browning
Journal:  JCI Insight       Date:  2019-04-23

Review 5.  Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.

Authors:  Varman T Samuel; Gerald I Shulman
Journal:  Cell Metab       Date:  2017-08-31       Impact factor: 27.287

6.  Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis.

Authors:  Fernando Bril; Romina Lomonaco; Beverly Orsak; Carolina Ortiz-Lopez; Amy Webb; Fermin Tio; Joan Hecht; Kenneth Cusi
Journal:  Hepatology       Date:  2014-04-25       Impact factor: 17.425

7.  Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction.

Authors:  Erik Kirk; Dominic N Reeds; Brian N Finck; S Mitra Mayurranjan; Mitra S Mayurranjan; Bruce W Patterson; Samuel Klein
Journal:  Gastroenterology       Date:  2009-01-25       Impact factor: 22.682

8.  Insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients.

Authors:  T-J Hsiao; J-C Chen; J-D Wang
Journal:  Int J Obes Relat Metab Disord       Date:  2004-01

9.  Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease.

Authors:  Jung Won Yun; Yong Kyun Cho; Jung Ho Park; Hong Joo Kim; Dong Il Park; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim
Journal:  Liver Int       Date:  2009-04       Impact factor: 5.828

10.  Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease.

Authors:  Panu K Luukkonen; Sylvie Dufour; Kun Lyu; Xian-Man Zhang; Antti Hakkarainen; Tiina E Lehtimäki; Gary W Cline; Kitt Falk Petersen; Gerald I Shulman; Hannele Yki-Järvinen
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.